National Institute of Allergy And Infectious Diseases; Notice of Closed Meetings, 96024 [2016-31610]
Download as PDF
96024
Federal Register / Vol. 81, No. 250 / Thursday, December 29, 2016 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, Conference Room 10, 31 Center
Drive, Bethesda, MD 20892.
Open: 9:30 a.m. to 3:15 p.m.
Agenda: A report from the Institute
Director and other staff.
Place: National Institutes of Health,
Building 31, Conference Room 10, 31 Center
Drive, Bethesda, MD 20892.
Contact Person: Martin H. Goldrosen,
Ph.D., Director, Division of Extramural
Activities, National Center for
Complementary and Integrative Health, NIH,
6707 Democracy Blvd., Ste. 401, Bethesda,
MD 20892–5475, (301) 594–2014,
goldrosm@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
nccih.nih.gov/about/naccih/, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Integrative Health,
National Institutes of Health, HHS)
Dated: December 22, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Peer Review Meeting.
Date: January 11–12, 2017.
Time: 7:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Hilton Garden Inn Savannah
Historic District, Telfair Conference Room,
321 West Bay Street, Savannah, GA 31401.
Contact Person: Ellen S. Buczko, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room #3F30A, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892 –9823, (240) 669–5028,
ebuczko1@niaid.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: January 25–26, 2017.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Room
3G53, 5601 Fishers Lane, Rockville, MD
20892 (Telephone Conference Call).
Contact Person: Julio Aliberti, Scientific
Review Officer, Scientific Review Program,
DEA/NIAID/NIH/DHHS, 5601 Fishers Lane,
MSC–9823, Rockville, MD 20852, 301–761–
7322, alibertijc@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 23, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–31430 Filed 12–28–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2016–31610 Filed 12–28–16; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
asabaliauskas on DSK3SPTVN1PROD with NOTICES
National Institute of Allergy And
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
VerDate Sep<11>2014
18:41 Dec 28, 2016
Jkt 241001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Using Informatics To Improve Data
Analysis of Chemical Screening
Assays Conducted in Zebrafish; Notice
of Webinars; Registration Information
The National Toxicology
Program (NTP) at the National Institute
of Environmental Health Sciences
announces the webinar series, ‘‘Using
Informatics to Improve Data Analysis of
Chemical Screening Assays Conducted
in Zebrafish.’’ The webinars will
SUMMARY:
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
provide an overview of current issues
that need to be addressed to facilitate
the broader use of zebrafish for chemical
safety screening studies and how data
science can be applied to address some
of those issues.
DATES: First Webinar: February 2, 2017,
from 11:30 a.m. to 1:00 p.m. Eastern
Standard Time (EST).
Subsequent Webinars: February 16,
2017; March 2, 2017; both webinars will
be presented from 11:30 a.m. to 12:30
p.m. EST.
Registration for Webinars:
Registration will be open continuously;
registration for any webinar will
automatically register the participant for
all subsequent webinars.
ADDRESSES: Web page: The preliminary
agenda, registration, and other meeting
materials are at https://ntp.niehs.nih.gov/
go/zfweb-2017.
FOR FURTHER INFORMATION CONTACT: Dr.
Elizabeth Maull, NTP Interagency
Center for the Evaluation of Alternative
Toxicological Methods (NICEATM), at
telephone: (919) 316–4668 or email:
maull@niehs.nih.gov.
SUPPLEMENTARY INFORMATION:
Background: The small size and rapid
development of the zebrafish make it a
useful vertebrate model for assessing
potential effects of chemicals on
development in a medium to highthroughput manner. However, a lack of
harmonization in several key protocol
components hinders the broader
adoption of the zebrafish model for
toxicological screening. In an effort to
address this issue, NTP launched the
Systematic Evaluation of the
Application of Zebrafish in Toxicology
(SEAZIT) program.
SEAZIT is addressing the issues of
variability among laboratories in the
endpoints measured, as well as the
nomenclature used for each endpoint.
NICEATM is organizing a webinar series
in support of the SEAZIT program that
will consider how these issues might be
addressed by implementation of
standardized nomenclature systems,
also known as ontologies.
Webinars in this series will (1)
summarize some of the barriers to
routine use of zebrafish in toxicological
evaluations, (2) review the concept of
ontologies, and (3) consider how
ontologies could be applied to
harmonize procedures used for
zebrafish screening studies.
Webinar Topics and Other
Information: A link to registration and
additional information about the
webinar series, including topics and
speakers for all webinars, are available
at https://ntp.niehs.nih.gov/go/zfweb2017. The webinar steering committee is
E:\FR\FM\29DEN1.SGM
29DEN1
Agencies
[Federal Register Volume 81, Number 250 (Thursday, December 29, 2016)]
[Notices]
[Page 96024]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-31610]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy And Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Peer Review Meeting.
Date: January 11-12, 2017.
Time: 7:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: Hilton Garden Inn Savannah Historic District, Telfair
Conference Room, 321 West Bay Street, Savannah, GA 31401.
Contact Person: Ellen S. Buczko, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, Room #3F30A, National Institutes of Health/NIAID, 5601
Fishers Lane, MSC 9823, Bethesda, MD 20892 -9823, (240) 669-5028,
ebuczko1@niaid.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: January 25-26, 2017.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Room 3G53, 5601 Fishers
Lane, Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Julio Aliberti, Scientific Review Officer,
Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers Lane,
MSC-9823, Rockville, MD 20852, 301-761-7322,
alibertijc@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: December 23, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-31610 Filed 12-28-16; 8:45 am]
BILLING CODE 4140-01-P